Literature DB >> 137591

Immunofluorescence studies of malignant lymphomas in formalin fixed material.

H Denk, T Radaszkiewicz, C Witting.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 137591     DOI: 10.1007/bf00284750

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


× No keyword cloud information.
  4 in total

1.  Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.

Authors:  S N Huang
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

2.  An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease.

Authors:  C R Taylor
Journal:  Eur J Cancer       Date:  1976-01       Impact factor: 9.162

3.  Immunofluorescence studies on pathologic routine material: application to malignant lymphomas.

Authors:  H Denk; T Radaszkiewicz; C Witting
Journal:  Beitr Pathol       Date:  1976-11

4.  Cytological and functional criteria for the classification of malignant lymphomata.

Authors:  K Lennert; H Stein; E Kaiserling
Journal:  Br J Cancer Suppl       Date:  1975-03
  4 in total
  4 in total

1.  [Immunofluorescence studies of experimental glomerulonephritis in formalin-fixed and paraffin-embedded material (author's transl)].

Authors:  C Witting
Journal:  Klin Wochenschr       Date:  1977-06-01

2.  [Angioimmunoblastic lymphadenopathy and persistent virus infection? Discussion of immunohistological findings on two cases (author's trsnsl)].

Authors:  M Bergholz; H H Bartsch; G R Krueger; A Schauer; R Fischer
Journal:  Klin Wochenschr       Date:  1979-12-17

3.  A comparative immunofluorescent study of fixed decalcified tissue and frozen non-decalcified tissue from the guinea pig cochlea.

Authors:  A M Soliman
Journal:  Arch Otorhinolaryngol       Date:  1988

4.  Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL).

Authors:  G R Krueger; M Bergholz; H H Bartsch; R Fischer; A Schauer
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.